AASLD Webinars are online educational sessions that bring together a wide range of professionals to discuss the latest controversies and issues in the various sub-specialty fields of hepatology. Through these short, innovative sessions, participants can ask the experts questions about hot topics within their respective fields. Webinars are held throughout the year, with some presentations posted to LiverLearning®.


2022 Webinars


Management of Autoimmune Hepatitis Not Achieving Remission
Presented by the Clinical Practice Special Interest Group

A New Worldwide Enigma: Increased Reporting of Cases of Acute Hepatitis in Children
Jointly Presented by the North American Society for Pediatric Gastroenterology (NASPGHAN) and AASLD 

Using Mass Cytometry to Decipher Mechanisms of Liver Diseases
Presented by the Liver Cell Biology in Hepatic Diseases SIG

The Art and Science of Managing Acute on Chronic Liver Failure
Presented by the Acute on Chronic Liver Failure Special Interest Group

Endovascular vs Endoscopic Management of Gastric Varices: Which is Better?
Presented by the Portal Hypertension Clinical and Experimental Special Interest Group

Covid in Focus: Outpatient Therapeutics and Managing Liver Transplant Donors and Recipients
Presented by the AASLD COVID-19 Task Force's Clinical Oversight and Education Subcommittee 

Applications of TIPS for Portal Hypertension: Entering a New Era (Now Available)
Presented by the Portal Hypertension Special Interest Group

Going Beyond the Statement: Improving Diversity, Equity and Inclusion in Hepatology
Presented by the Inclusion and Diversity Committee

Getting the Most Out of the Mentor-Mentee Relationship
Presented by the Membership and Mentorship Committee

HBV DNA Integration: Mechanisms, Pathogenesis and Clinical Relevance in Liver Disease Progression and Functional Cure
Presented by the Hepatitis B Special Interest Group


2021 Webinars


PSC and Hepatic Fibrosis: An Update from the Field
Presented by the Liver Fibrosis Special Interest Group

AASLD's Thought Leaders Series: How I Manage My Practice
Presented by the AASLD President

Microbiome in NASH and Cirrhosis
Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group

Promoting Equity, Diversity and Inclusion in Communication Near the End of Life
Presented by the Membership and Mentorship and Inclusion and Diversity Committees

NASH Congressional Briefing
Presented by AASLD and the Global Liver Institute

How Can Patients Get Involved with The Liver Meeting
Presented by the Public Policy Committee

Biliary Atresia: Where Are We and Where Do We Go From Here?
Presented by the Pediatric Liver Disorders Special Interest Group

The Use of Quantitative HBsAg in Clinical Practice
Presented by the Hepatitis B Special Interest Group

Cardiovascular Disease in NASH Patients
Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group

Genetics of NAFLD
Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group

Gaps in Advance Care Planning at Transplant Centers: Call for Action
Presented by the Public Health/Healthcare Delivery Special Interest Group

NASH as a Cause of Hepatocellular Carcinoma
Presented by the Non-alcoholic Fatty Liver Disease Special Interest Group

Natural History of NAFLD/NASH in Children: Knowledge, Gaps and Interventions
Presented by the Pediatric Liver Disorders Special Interest Group

Challenges in NASH Clinical Trials
Presented by the Non-alcoholic Fatty Liver Disease Special Interest Group

Acute on Chronic Liver Failure (ACLF) in Alcohol-associated Liver Disease (ALD)
Presented by the Acute on Chronic Liver Failure and Alcohol-associated Liver Disease Special Interest Groups

FY21 Peer Reviewed Cancer Research Program Funding Opportunities in Liver Cancer
Presented by the Public Policy Committee

Simultaneous Liver Kidney Transplant: How Did We Do With the New Criteria?
Presented by the Liver Transplantation and Surgery Special Interest Group

Use of Serum and Imaging Biomarkers of NAFLD/NASH in Clinical Practice
Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group

Developing a Career in Clinical Research
Presented by the Hepatitis B Special Interest Group

To Stop or Not to Stop: The Practice of Finite Nucleos(T)ide Analog Therapy
Presented by the Hepatitis B Special Interest Group

Practical Approach to Coagulation Management in Cirrhosis
Presented by the Clinical Practice Special Interest Group


2020 Webinars


New E/M Requirements are Coming January 1: Will You be Ready?
Presented by the Public Policy Committee

Chronic Hepatitis C 500: The Advanced Course
Presented by the Hepatitis C Special Interest Group

Treatment Strategies for Autoimmune Hepatitis Beyond First-line Therapy
Presented by the Cholestatic and Autoimmune Liver Diseases Special Interest Group

Novel Models for HCV Care Delivery
Presented by the Hepatitis C Special Interest Group

Current and Future Disease Burden of HBV: Global and Regional Perspectives (Live Q&A Panel Discussion) Presented by the Hepatitis B Special Interest Group

Global Public Health Strategies for the Prevention of ALD in 2020
Presented by the Alcohol-associated Liver Disease Special Interest Group

Dietary Recommendations for NAFLD Patients: What Do I Tell My Patients?
Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group

Hepatitis C: Infection Beyond the Liver
Presented by the Hepatitis C Special Interest Group

Chronic Hepatitis C 101: The Basics
Presented by the Hepatitis C Special Interest Group

Prevention and Management of Ascites in Cirrhosis: Controversies and New Approaches
Presented by the Portal Hypertension Special Interest Group

Implementation Science of Patient Reported Outcomes (PROs)
Presented by the Public Health/Healthcare Delivery Special Interest Group

NLRB - How Is It Working So Far?
Presented by the Liver Transplantation journal

Are You Digitally Secure?
Presented by the Communications and Technology Committee


2019 Webinars


Cannabis and The Liver: Update for the Hepatologist
Presented by the Clinical Practice Special Interest Group


Integrated Management of Alcohol-Related Liver Disease with Hepatologists and Addiction Specialists
Presented by the Alcohol-Related Liver Disease Special Interest Group


The Diverse Presentation and Diagnosis of Liver Injury Due to Drugs or Herbal and Dietary Supplements Presented by the Hepatotoxicity Special Interest Group


Systematic Screening for NAFLD-Related Advanced Fibrosis in Patient with Type 2 Diabetes, Where Do We Stand?
Presented by the Non-alcoholic Fatty Liver Disease Special Interest Group


Liquid Biopsy in Hepatocellular Carcinoma: Applications in Surveillance and Prediction of Treatment Response Presented by the Hepatobiliary Neoplasia Special Interest Group


Overview of Transplantation for Acute on Chronic Liver Failure
Presented by the Acute on Chronic Liver Failure Special Interest Group


New Insights into the Pathogenesis and Management of Cystic Fibrosis-Related Liver Disease
Presented by the Pediatric Liver Disorders Special Interest Group


HCC Staging and Treatments
Presented by the Hepatology Associates Special Interest Group


Palliative Care: What It Is and When To Use It
Presented by the Public Health/Health Care Delivery Special Interest Group


HBV Reactivation: How to Approach the Immunosuppressed Patient
Presented by the Hepatitis B Special Interest Group


The 2018 Primary Biliary Cholangitis Practice Guidance: Highlights
Presented by the Cholestatic and Autoimmune Liver Diseases Special Interest Group


Early Liver Transplantation in Alcoholic Hepatitis
Presented by the Alcoholic Liver Disease Special Interest Group


Challenges in Antiviral Therapy for Hepatitis C

Presented by the Hepatitis C Special Interest Group


Evaluation of Renal Dysfunction and Hyponatremia in Patients with Cirrhosis
Presented by the Clinical Practice Special Interest Group

HCV Treatment in Patients with IDU
Presented by the Hepatitis C Special Interest Group

Management of NAFLD: Integrating Strategies from Obesity Medicine into Clinical Practice
Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group

Liver Lesions 101
Presented by the Hepatology Associates Special Interest Group



2018 Webinars


Best Practices for Managing Cardiovascular Risk After Liver Transplantation
Presented by the Cardiopulmonary Affinity Group


HBV - Update on the Guidelines and Controversies in Management
Presented by the Hepatitis B Special Interest Group


Cardiac Risk in Liver Transplantation: Getting to the “Heart” of the Matter
Presented by the Cardiopulmonary Affinity Group


Implications of the Hepatitis C Epidemic on Women & Children
Presented by the Hepatitis C Special Interest Group


Unraveling the New UNOS Liver Allocation Policy
Presented by the Liver Transplantation and Surgery SIG & Liver Transplantation Journal


Role of Diet and Exercise in the Management of NAFLD
Presented by the Non-Alcoholic Fatty Liver Disease Special Interest Group


Cost-Effective Approach to Evaluation of Abnormal Liver Enzymes
Presented by the Clinical Practice Special Interest Group


Acute on Chronic Liver Failure in Children
Presented by the Pediatric Liver Disorders Special Interest Group


Surgical Risk in the Portal Hypertensive Patient
Presented by the Portal Hypertension Special Interest Group


2017 Webinars


Portal Vein Thrombosis in Cirrhosis: Causes and Consequences
Presented by the Portal Hypertension Special Interest Group


Controversy Regarding HCV Treatment and HCC Recurrence
Presented by the Hepatobiliary Neoplasia Special Interest Group


Frailty the “Sixth Vital Sign” in Cirrhosis - How Do We Diagnose It and What Can We Do When We Find It? Presented by the Acute on Chronic Liver Failure Special Interest Group


Fibrosis Regression: Mechanisms and Clinical Consequences
Presented by the Liver Fibrosis Special Interest Group


Chronic Hepatitis B and Pregnancy: Management and Prevention of Vertical Transmission
Presented by the Hepatitis B Special Interest Group


Surrogate Endpoints in Primary Sclerosing Cholangitis (PSC)
Presented by the Cholestatic and Biliary Diseases Special Interest Group


New DAA's and Controversies in HCV: What Clinicians Need to Know
Presented by the Hepatitis C Special Interest Group